{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:35:06Z","timestamp":1791819306370,"version":"4.3.4"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:p>Monoclonal gammopathies are characterized by the overproduction of monoclonal Ig (MIg) detectable in the serum or urine resulting from a clonal proliferation of plasma cells or B lymphocytes. The underlying hematologic conditions range from malignant neoplasms of plasma cells or B lymphocytes, including multiple myeloma and B-cell lymphoproliferative disorders, to nonmalignant small clonal proliferations. The term MGUS implies presence of an MIg in the setting of a \u201cbenign\u201d hematologic condition without renal or other end organ damage. The term MGRS was recently introduced to indicate monoclonal gammopathy with MIg-associated renal disease in the absence of hematologic malignancy. Most MIg-associated renal diseases result from the direct deposition of nephrotoxic MIg or its light- or heavy-chain fragments in various renal tissue compartments. Immunofluorescence microscopy is essential to identify the offending MIg and define its tissue distribution. Mass spectrometry is helpful in difficult cases. Conditions caused by direct tissue deposition of MIg include common disorders, such as cast nephropathy, amyloidosis, and MIg deposition diseases, as well as uncommon disorders, such as immunotactoid glomerulopathy, proliferative GN with MIg deposits, light-chain proximal tubulopathy, and the rare entities of crystal-storing histiocytosis and crystalglobulinemia. Indirect mechanisms of MIg-induced renal disease can cause C3 glomerulopathy or thrombotic microangiopathy without tissue MIg deposits. Treatment of MIg-associated renal disease is aimed at eliminating the clonal plasma cell or B-cell population as appropriate. Both the renal and the underlying hematologic disorders influence the management and prognosis of MIg-associated renal diseases.<\/jats:p>","DOI":"10.1681\/asn.2017121319","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T09:15:07Z","timestamp":1524820507000},"page":"1810-1823","source":"Crossref","is-referenced-by-count":149,"title":["The Complexity and Heterogeneity of Monoclonal Immunoglobulin\u2013Associated Renal Diseases"],"prefix":"10.1681","volume":"29","author":[{"given":"Sanjeev","family":"Sethi","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivette D.","family":"D\u2019Agati","sequence":"additional","affiliation":[{"name":"Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"B1-20230829","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance.","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"B2-20230829","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/leu.2008.291","article-title":"Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.","volume":"23","author":"Kyle","year":"2009","journal-title":"Leukemia"},{"key":"B3-20230829","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood-2006-03-001164","article-title":"Dangerous small B-cell clones.","volume":"108","author":"Merlini","year":"2006","journal-title":"Blood"},{"key":"B4-20230829","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1200\/JCO.2013.50.8499","article-title":"Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis.","volume":"31","author":"Kourelis","year":"2013","journal-title":"J Clin Oncol"},{"key":"B5-20230829","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International myeloma working group updated criteria for the diagnosis of multiple myeloma.","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"B6-20230829","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1182\/blood-2013-05-495929","article-title":"How I treat monoclonal gammopathy of renal significance (MGRS).","volume":"122","author":"Fermand","year":"2013","journal-title":"Blood"},{"key":"B7-20230829","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ki.2014.408","article-title":"Diagnosis of monoclonal gammopathy of renal significance.","volume":"87","author":"Bridoux","year":"2015","journal-title":"Kidney Int"},{"key":"B8-20230829","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2215\/CJN.06760909","article-title":"Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy.","volume":"5","author":"Sethi","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B9-20230829","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","article-title":"Monoclonal gammopathy of renal significance: When MGUS is no longer undetermined or insignificant.","volume":"120","author":"Leung","year":"2012","journal-title":"Blood"},{"key":"B10-20230829","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2215\/CJN.05750710","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft.","volume":"6","author":"Nasr","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B11-20230829","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","article-title":"Serum reference intervals and diagnostic ranges for free \u03ba and free \u03bb immunoglobulin light chains: Relative sensitivity for detection of monoclonal light chains.","volume":"48","author":"Katzmann","year":"2002","journal-title":"Clin Chem"},{"key":"B12-20230829","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2215\/CJN.02290508","article-title":"Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.","volume":"3","author":"Hutchison","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"B13-20230829","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.mayocp.2013.08.002","article-title":"Monoclonal gammopathy-associated proliferative glomerulonephritis.","volume":"88","author":"Sethi","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"B14-20230829","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ki.2012.108","article-title":"Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis.","volume":"82","author":"Sethi","year":"2012","journal-title":"Kidney Int"},{"key":"B15-20230829","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2215\/CJN.10491012","article-title":"Renal amyloidosis: Origin and clinicopathologic correlations of 474 recent cases.","volume":"8","author":"Said","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B16-20230829","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2012-03-413682","article-title":"How I treat amyloidosis: The importance of accurate diagnosis and amyloid typing.","volume":"120","author":"Leung","year":"2012","journal-title":"Blood"},{"key":"B17-20230829","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1182\/blood-2009-07-230722","article-title":"Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens.","volume":"114","author":"Vrana","year":"2009","journal-title":"Blood"},{"key":"B18-20230829","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.2215\/CJN.02890310","article-title":"Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis.","volume":"5","author":"Sethi","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B19-20230829","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1182\/blood-2014-11-609883","article-title":"A practical approach to the diagnosis of systemic amyloidoses.","volume":"125","author":"Fern\u00e1ndez de Larrea","year":"2015","journal-title":"Blood"},{"key":"B20-20230829","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/ndt\/gfr381","article-title":"Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney.","volume":"27","author":"Eirin","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B21-20230829","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0272-6386(99)70432-4","article-title":"Heavy chain deposition disease: The disease spectrum.","volume":"33","author":"Kambham","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"B22-20230829","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1681\/ASN.V103519","article-title":"Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking C(H)1.","volume":"10","author":"Moulin","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"B23-20230829","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2215\/CJN.08640811","article-title":"Renal monoclonal immunoglobulin deposition disease: A report of 64 patients from a single institution.","volume":"7","author":"Nasr","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B24-20230829","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1681\/ASN.V1271482","article-title":"Renal monoclonal immunoglobulin deposition disease: The disease spectrum.","volume":"12","author":"Lin","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"B25-20230829","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1053\/j.ajkd.2011.05.022","article-title":"Renal crescentic alpha heavy chain deposition disease: A report of 3 cases and review of the literature.","volume":"58","author":"Alexander","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"B26-20230829","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5858\/133.2.249","article-title":"Renal lesions associated with plasma cell dyscrasias: Practical approach to diagnosis, new concepts, and challenges.","volume":"133","author":"Herrera","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"B27-20230829","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.kint.2016.09.004","article-title":"Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.","volume":"91","author":"Bridoux","year":"2017","journal-title":"Kidney Int"},{"key":"B28-20230829","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.kint.2016.10.026","article-title":"The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits.","volume":"91","author":"Vignon","year":"2017","journal-title":"Kidney Int"},{"key":"B29-20230829","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1053\/j.ajkd.2003.08.040","article-title":"Light chain deposition disease with renal involvement: Clinical characteristics and prognostic factors.","volume":"42","author":"Pozzi","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"B30-20230829","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1681\/ASN.2009010110","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits.","volume":"20","author":"Nasr","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B31-20230829","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.mayocp.2015.01.024","article-title":"Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits.","volume":"90","author":"Bhutani","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"B32-20230829","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","article-title":"The cryoglobulinaemias.","volume":"379","author":"Ramos-Casals","year":"2012","journal-title":"Lancet"},{"key":"B33-20230829","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients.","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"B34-20230829","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.ASN.0000013397.06964.19","article-title":"Immunotactoid glomerulopathy.","volume":"13","author":"Schwartz","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"B35-20230829","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1046\/j.1523-1755.2003.00853.x","article-title":"Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.","volume":"63","author":"Rosenstock","year":"2003","journal-title":"Kidney Int"},{"key":"B36-20230829","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1046\/j.1523-1755.2002.00628.x","article-title":"Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features.","volume":"62","author":"Bridoux","year":"2002","journal-title":"Kidney Int"},{"key":"B37-20230829","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2215\/CJN.08300910","article-title":"Fibrillary glomerulonephritis: A report of 66 cases from a single institution.","volume":"6","author":"Nasr","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B38-20230829","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0272-6386(12)70138-5","article-title":"Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy.","volume":"22","author":"Fogo","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"B39-20230829","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1093\/ndt\/gfs348","article-title":"Immunotactoid glomerulopathy: Clinicopathologic and proteomic study.","volume":"27","author":"Nasr","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B40-20230829","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/ajkd.1998.v32.pm9740176","article-title":"The kidney in plasma cell dyscrasias: Bence-Jones cast nephropathy and light chain deposit disease.","volume":"32","author":"Cohen","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"B41-20230829","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1053\/j.ajkd.2011.12.028","article-title":"Clinicopathologic correlations in multiple myeloma: A case series of 190 patients with kidney biopsies.","volume":"59","author":"Nasr","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"B42-20230829","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00125480-200401000-00005","article-title":"Dysproteinemia and the kidney.","volume":"11","author":"Markowitz","year":"2004","journal-title":"Adv Anat Pathol"},{"key":"B43-20230829","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1681\/ASN.2015020185","article-title":"Light chain proximal tubulopathy: Clinical and pathologic characteristics in the modern treatment era.","volume":"27","author":"Stokes","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B44-20230829","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/modpathol.2011.104","article-title":"The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation.","volume":"24","author":"Larsen","year":"2011","journal-title":"Mod Pathol"},{"key":"B45-20230829","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00005792-200005000-00002","article-title":"Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients.","volume":"79","author":"Messiaen","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"B46-20230829","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/sj.ki.5001990","article-title":"Immunofluorescence on pronase-digested paraffin sections: A valuable salvage technique for renal biopsies.","volume":"70","author":"Nasr","year":"2006","journal-title":"Kidney Int"},{"key":"B47-20230829","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/leu.2016.195","article-title":"Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: A retrospective series of 49 patients.","volume":"31","author":"Vignon","year":"2017","journal-title":"Leukemia"},{"key":"B48-20230829","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1053\/ajkd.2002.29914","article-title":"Crystal-storing histiocytosis involving the kidney in a low-grade B-cell lymphoproliferative disorder.","volume":"39","author":"Sethi","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"B49-20230829","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/ndt\/gfq129","article-title":"Crystal-storing histiocytosis with renal Fanconi syndrome: Pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome.","volume":"25","author":"El Hamel","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"B50-20230829","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1681\/ASN.2014050509","article-title":"Crystalglobulin-induced nephropathy.","volume":"26","author":"Gupta","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B51-20230829","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0046-8177(99)90166-1","article-title":"Crystal-storing histiocytosis: A disorder occurring in plasmacytic tumors expressing immunoglobulin kappa light chain.","volume":"30","author":"Jones","year":"1999","journal-title":"Hum Pathol"},{"key":"B52-20230829","first-page":"351","article-title":"Crystal-storing histiocytosis and crystalline tissue deposition in multiple myeloma.","volume":"115","author":"Yamamoto","year":"1991","journal-title":"Arch Pathol Lab Med"},{"key":"B53-20230829","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.ki.5001524","article-title":"Dysproteinemia-related nephropathy associated with crystal-storing histiocytosis.","volume":"70","author":"Stokes","year":"2006","journal-title":"Kidney Int"},{"key":"B54-20230829","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/ckj\/sfu025","article-title":"Crystalloid glomerulopathy in monoclonal gammopathy of renal significance (MGRS).","volume":"7","author":"Vankalakunti","year":"2014","journal-title":"Clin Kidney J"},{"key":"B55-20230829","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/1097-0142(19930215)71:4<1231::AID-CNCR2820710410>3.0.CO;2-J","article-title":"Crystalglobulinemia syndrome. A manifestation of multiple myeloma.","volume":"71","author":"Ball","year":"1993","journal-title":"Cancer"},{"key":"B56-20230829","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jmg.2006.045328","article-title":"Primary glomerulonephritis with isolated C3 deposits: A new entity which shares common genetic risk factors with haemolytic uraemic syndrome.","volume":"44","author":"Servais","year":"2007","journal-title":"J Med Genet"},{"key":"B57-20230829","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.2012.212","article-title":"C3 glomerulonephritis: Clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.","volume":"82","author":"Sethi","year":"2012","journal-title":"Kidney Int"},{"key":"B58-20230829","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2215\/CJN.07110810","article-title":"Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.","volume":"6","author":"Sethi","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B59-20230829","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: Consensus report.","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int"},{"key":"B60-20230829","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ki.2013.340","article-title":"Toward a working definition of C3 glomerulopathy by immunofluorescence.","volume":"85","author":"Hou","year":"2014","journal-title":"Kidney Int"},{"key":"B61-20230829","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMra1108178","article-title":"Membranoproliferative glomerulonephritis--a new look at an old entity.","volume":"366","author":"Sethi","year":"2012","journal-title":"N Engl J Med"},{"key":"B62-20230829","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1053\/j.ajkd.2010.06.021","article-title":"Dense deposit disease associated with monoclonal gammopathy of undetermined significance.","volume":"56","author":"Sethi","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"B63-20230829","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2215\/CJN.06180710","article-title":"Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: A fortuitous association?","volume":"6","author":"Bridoux","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B64-20230829","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1053\/j.ajkd.2013.02.370","article-title":"C3 glomerulonephritis associated with monoclonal gammopathy: A case series.","volume":"62","author":"Zand","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"B65-20230829","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5414\/CN108363","article-title":"Refractory atypical hemolytic uremic syndrome with monoclonal gammopathy responsive to bortezomib-based therapy.","volume":"83","author":"Cheungpasitporn","year":"2015","journal-title":"Clin Nephrol"},{"key":"B66-20230829","article-title":"C3 glomerulopathy associated with monoclonal Ig: A distinct subtype.","author":"Ravindran","journal-title":"Kidney Int"},{"key":"B67-20230829","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2215\/CJN.03480708","article-title":"Dense deposit disease: Clinicopathologic study of 32 pediatric and adult patients.","volume":"4","author":"Nasr","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B68-20230829","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1182\/blood-2016-08-737163","article-title":"Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy.","volume":"129","author":"Chauvet","year":"2017","journal-title":"Blood"},{"key":"B69-20230829","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.kint.2016.09.045","article-title":"Thrombotic microangiopathy associated with monoclonal gammopathy.","volume":"91","author":"Ravindran","year":"2017","journal-title":"Kidney Int"},{"key":"B70-20230829","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome.","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"B71-20230829","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: A retrospective population-based cohort study.","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet"},{"key":"B72-20230829","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance.","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"key":"B73-20230829","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MNH.0b013e32835fe37c","article-title":"Mass spectrometry based proteomics in the diagnosis of kidney disease.","volume":"22","author":"Sethi","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B74-20230829","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.humpath.2014.02.020","article-title":"Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining.","volume":"45","author":"Paueksakon","year":"2014","journal-title":"Hum Pathol"},{"key":"B75-20230829","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1681\/ASN.2017030306","article-title":"DnaJ heat shock protein family B member 9 is a novel biomarker for fibrillary GN.","volume":"29","author":"Dasari","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B76-20230829","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1681\/ASN.2017050566","article-title":"DnaJ homolog subfamily B member 9 is a putative autoantigen in fibrillary GN.","volume":"29","author":"Andeen","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B77-20230829","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1681\/ASN.2014050481","article-title":"IgD heavy-chain deposition disease: Detection by laser microdissection and mass spectrometry.","volume":"26","author":"Royal","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B78-20230829","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.ajkd.2013.09.007","article-title":"Membranoproliferative glomerulonephritis: The role for laser microdissection and mass spectrometry.","volume":"63","author":"Jain","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B79-20230829","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ki.2015.195","article-title":"Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits.","volume":"88","author":"Larsen","year":"2015","journal-title":"Kidney Int"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201807000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:30:52Z","timestamp":1786131052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201807000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":79,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2017121319","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]}}}